This article is more than 5 years old. Information may no longer be current.
Olopatadine aids CL wearers with allergic conjunctivitis
Click Here to Manage Email Alerts
Olopatadine provides better comfort than placebo to contact lens wearers with signs and symptoms of seasonal allergic conjunctivitis, according to a study.
Miguel Brodsky, MD, and colleagues tested the comfort of olopatadine in a double-masked controlled study. They randomized CL-wearing subjects with a history of allergic conjunctivitis to receive either olopatadine or placebo bilaterally. Allergen challenge was performed 10 minutes after CL insertion
After medication instillation, after lens insertion and at time points from 1 to 10 minutes after allergen challenge, self-reported ocular comfort was statistically significantly superior in people who received olopatadine, compared to those who received placebo.
The study is published in Eye & Contact Lens: Science and Clinical Practice.